Controlled-release solid dosage forms of mesalamine
US10071058B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2013 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Mar 24, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2846
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-release solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention relates to a method of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowel disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.